🔍 Definition
Shock is a life-threatening, time-sensitive syndrome of acute circulatory failure resulting in inadequate oxygen delivery to meet cellular metabolic demands, leading to cellular dysfunction, organ injury, and death if untreated. The clinical hallmark is end-organ hypoperfusion — not merely hypotension. Per the NCBI Shock Reference, the cardinal features are: (1) hemodynamic instability, (2) evidence of tissue hypoperfusion, and (3) cellular metabolic dysfunction.
Critical documentation principle: Isolated hypotension (e.g., SBP < 90 mmHg) without documented end-organ hypoperfusion — such as elevated lactate, acute kidney injury, altered mental status, oliguria, or abnormal liver function — does not automatically meet clinical criteria for shock. Documentation must reflect both the hemodynamic instability and the evidence of impaired perfusion to support the diagnosis.
The five principal shock subtypes recognized in ICD-10-CM FY2027 are:
- Septic shock (R65.21): Shock due to systemic infection with persistent hypotension requiring vasopressors and lactate >2 mmol/L despite adequate fluid resuscitation — per Sepsis-3 definition (Singer et al., JAMA 2016).
- Cardiogenic shock (R57.0): Pump failure with SBP <90 mmHg for >30 minutes, cardiac index (CI) <2.2 L/min/m², pulmonary capillary wedge pressure (PCWP) >15 mmHg, and evidence of hypoperfusion.
- Hypovolemic shock (R57.1): Reduced intravascular volume from hemorrhage, dehydration, or third-spacing, causing inadequate preload and reduced cardiac output.
- Obstructive shock: Mechanical obstruction to blood flow — classically pulmonary embolism (I26.x), cardiac tamponade (I31.4), or tension pneumothorax. Coded via the underlying cause in ICD-10-CM.
- Anaphylactic shock (T78.2xxA, T80.5xxA, T88.6xxA, T78.00xA–T78.09xA): Severe, systemic allergic response causing distributive shock via massive histamine release and vasodilation.
🗂️ Alternative Terminology
Clinical staff use varied terminology in documentation. The following table lists formal, colloquial, and lay terms that coders and CDI specialists must recognize to support appropriate code assignment and query triggers.
| Formal / Clinical Term | Colloquial / Lay Names / Synonyms / Abbreviations |
|---|---|
| Septic shock (R65.21) | Sepsis-induced hypotension, septic circulatory failure, vasodilatory shock from sepsis, refractory septic shock |
| Severe sepsis without septic shock (R65.20) | Sepsis with organ dysfunction, sepsis + acute organ failure, sepsis-associated organ dysfunction |
| Cardiogenic shock (R57.0) | Pump failure shock, cardiac shock, low-output shock, hemodynamic collapse, CS, CS-AMI (cardiogenic shock complicating AMI) |
| Hypovolemic shock (R57.1) | Hemorrhagic shock, volume-depletion shock, dehydration shock, fluid-loss shock, class III/IV hemorrhage |
| Obstructive shock | Mechanical shock, outflow obstruction shock, PE-induced shock (massive PE), tamponade shock, tension pneumo shock |
| Anaphylactic shock (T78.2xxA) | Allergic shock, anaphylaxis shock, Type I hypersensitivity shock, systemic anaphylaxis |
| Distributive shock | Vasodilatory shock, vasoplegic shock — encompasses septic, anaphylactic, neurogenic |
| Neurogenic shock (R57.8) | Spinal shock, sympathectomy shock — R57.8 (other shock); loss of sympathetic tone |
| Traumatic shock (T79.4xxA) | Injury shock, post-trauma shock, polytrauma hemodynamic failure |
| Postprocedural shock (T81.1x) | Post-op shock, post-surgical shock, operative shock, procedure-related hemodynamic failure |
| Toxic shock syndrome (A48.3) | TSS, staphylococcal toxic shock, streptococcal toxic shock; add B95–B96 organism code when documented |
| Obstetric shock (O75.1) | Shock during labor/delivery, parturient shock, obstetric circulatory collapse |
| Shock, unspecified (R57.9) | Undifferentiated shock, NOS shock — AUDIT TRAP; always query for type |
🩺 Signs & Symptoms
Clinical documentation must reflect specific signs, symptoms, and objective markers supporting each shock subtype. CDI specialists should flag encounters where shock is clinically evident but not explicitly named or typed by the provider.
Universal Shock Indicators (all subtypes)
- Hypotension: SBP <90 mmHg or MAP <65 mmHg — necessary but not sufficient alone
- Tachycardia: HR >100 bpm (compensatory); may be absent in neurogenic shock (bradycardia)
- Altered mental status: Confusion, agitation, obtundation, coma — cerebral hypoperfusion
- Oliguria / anuria: UO <0.5 mL/kg/hr — renal hypoperfusion; supports AKI coding (N17.x)
- Elevated lactate: >2 mmol/L (tissue hypoperfusion marker); >4 mmol/L = refractory/severe
- Cool, clammy, mottled skin: Peripheral vasoconstriction (hypovolemic, cardiogenic); warm/flushed in early distributive shock
- Capillary refill >2 seconds
- Metabolic acidosis: Lactic acidosis, elevated anion gap
Subtype-Specific Clinical Markers
| Shock Type | Key Clinical Features | Hemodynamic Profile |
|---|---|---|
| Septic (R65.21) | Known or suspected infection, fever/hypothermia, leukocytosis/leukopenia, elevated CRP/procalcitonin, vasopressor requirement, lactate >2 despite ≥30 mL/kg IVF | ↓SVR, ↑CO early (warm shock); ↓CO late; warm extremities early |
| Cardiogenic (R57.0) | Cool extremities, S3 gallop, elevated BNP/NT-proBNP, pulmonary edema, JVD, EF ≤30%, CI <2.2, PCWP >15 on Swan-Ganz | ↑SVR, ↓CO, ↓CI, ↑PCWP, ↑CVP |
| Hypovolemic (R57.1) | Active hemorrhage or fluid loss, flat neck veins, dry mucous membranes, hemoconcentration (↑Hct in dehydration), ↓CVP, ↓PCWP | ↑SVR, ↓CO, ↓CVP, ↓PCWP |
| Obstructive | PE: pleuritic chest pain, dyspnea, hypoxia, RV strain on EKG, ↑BNP. Tamponade: muffled heart sounds, JVD, pulsus paradoxus >10 mmHg (Beck’s triad) | ↑SVR, ↓CO, ↑CVP, normal/↓PCWP |
| Anaphylactic (T78.2xxA) | Urticaria, angioedema, bronchospasm, stridor, exposure history (food, drug, contrast, venom), ↓SVR, ↑HR, flushing | ↓SVR, ↑CO, ↓PCWP (distributive) |
Hypotension ≠ Shock. Per FY2027 ICD-10-CM Official Guidelines and clinical validity standards, a diagnosis of shock requires documentation of both hemodynamic instability AND evidence of end-organ hypoperfusion (elevated lactate, AKI, altered mental status, oliguria, or hepatic dysfunction). Code R57.x or R65.21 only when the provider has explicitly documented shock — do NOT infer the diagnosis from hemodynamic parameters alone without a provider statement.
🧭 Differential Diagnosis
Accurate shock subtype identification is critical for sequencing, DRG assignment, and HCC capture. The following differentials must be considered and — when co-existing conditions are confirmed — may require additional codes.
| Condition | Key Differentiating Features | ICD-10-CM |
|---|---|---|
| Septic shock | Infection source identified or suspected; vasopressor-dependent; lactate >2 despite fluids; positive cultures | A41.x (or specific infection) + R65.21 |
| Cardiogenic shock | Low EF, elevated BNP, cardiomegaly, AMI or cardiomyopathy history, CI <2.2, PCWP >15 | R57.0 ± I21.x (AMI) |
| Hypovolemic shock | Hemorrhage (trauma, GI bleed), dehydration, burns, vomiting/diarrhea; flat neck veins, ↓CVP | R57.1 + underlying cause (K92.1, S xx.x) |
| Massive pulmonary embolism | RV failure, hypoxia, CT-PA confirming PE, ↑troponin/BNP; “obstructive shock” mechanism | I26.02 (saddle PE w/ acute cor pulmonale) or I26.09/I26.99 |
| Cardiac tamponade | Beck’s triad, pulsus paradoxus, pericardial effusion on echo; obstructive mechanism | I31.4 + R57.0 (cardiogenic by mechanism) |
| Anaphylaxis | Allergen exposure, urticaria, angioedema, bronchospasm; rapid onset; epinephrine-responsive | T78.2xxA (unspecified cause) or T78.0x, T80.5, T88.6 |
| Neurogenic/spinal shock | SCI history, paradoxical bradycardia with hypotension, warm extremities, absent sympathetic response | R57.8 + S14.x or S24.x (SCI code) |
| Adrenal crisis (endocrine shock) | Adrenal insufficiency history, ↓Na, ↑K, ↓cortisol; refractory to vasopressors without steroids | R57.8 + E27.1 (primary AI) or E27.4x |
| Toxic shock syndrome | Toxin-mediated (Staph aureus or Group A Strep), fever, diffuse erythroderma, desquamation, multiorgan failure | A48.3; add B95–B96 organism code when documented |
| Vasoplegia post-cardiac surgery | Post-CPB vasodilation, warm shock, refractory to fluids, requires vasopressin/norepinephrine | T81.19xA (postprocedural shock) + I97.8x |
📋 Clinical Indicators
The following clinical indicators, when present in the medical record, should prompt documentation review and/or CDI query to ensure complete and accurate shock code assignment.
| Clinical Indicator | Documentation Required | Code Impact |
|---|---|---|
| Vasopressor administration (norepinephrine, vasopressin, dopamine, epinephrine, dobutamine) | Provider documents indication: septic shock, cardiogenic shock, or other shock type. Vasopressor use alone is insufficient — diagnosis of shock must be stated. | R65.21 (septic) or R57.0 (cardiogenic) — both MCC; major DRG impact |
| Lactate >2 mmol/L despite fluid resuscitation | Provider documents septic shock or acknowledges persistent hypoperfusion despite fluids + vasopressors | Supports R65.21 (required criterion for Sepsis-3 septic shock definition) |
| Blood cultures positive / infection source confirmed | Organism documented; systemic infection code (A41.x etc.) should appear as PDx when septic shock is present | A41.x as PDx + R65.21 as secondary — NEVER R65.21 as PDx |
| AMI documented with hemodynamic compromise | Provider explicitly links cardiogenic shock to acute MI (I21.x); supports DRG 219-221 | I21.x + R57.0 → AMI-shock DRG cluster; major reimbursement impact |
| Mechanical circulatory support device (IABP, Impella, ECMO, TandemHeart) | Device type and indication documented; supports cardiogenic shock coding and high-cost procedure DRG | R57.0 + procedure code (33990–33998 percutaneous VAD, as applicable; ECMO/ECLS codes 33946–33989, as applicable) |
| Allergic exposure + systemic reaction (urticaria, bronchospasm, hypotension) | Causative agent documented (food, drug, contrast, venom, unknown); route of exposure | T78.2xxA (unknown) vs. T78.0x (food) vs. T88.6xxA (drug) — 7th character required |
| Postprocedural hypotension/hemodynamic failure | Provider documents shock type in postoperative context; distinguish cardiogenic from septic from vasovagal | T81.10xA–T81.19xA (postprocedural shock subcategories) |
| Eclampsia/obstetric shock | Shock occurring during labor or within 24h of delivery documented in obstetric record | O75.1 — obstetric codes take precedence; do NOT use R57.x in obstetric context |
| Persistent hypotension without clear etiology | Provider assessment of shock type — query before accepting R57.9 (unspecified) | R57.9 is AUDIT TRAP; always query for subtype |
- 33994, 33996, 33998: added to the percutaneous VAD family for CPT 2027; not reportable for CPT 2026 dates of service.
- For 2026 dates of service, use the CPT 2026 VAD and ECMO/ECLS code set and descriptors in effect for that date of service.
Scenario: Chart reflects ICU admission with vasopressor requirement (norepinephrine drip), positive blood cultures (E. coli, A41.51), lactate 3.8 on admission, but provider discharge summary documents only “sepsis” without “shock.” Query: “Provider, please clarify the hemodynamic status during this admission. The chart reflects vasopressor requirement (norepinephrine) and lactate 3.8 mmol/L despite fluid resuscitation. Does this patient’s clinical course represent: (a) Septic shock (R65.21) — severe sepsis with vasopressor-requiring hypotension and lactate >2 despite resuscitation; (b) Severe sepsis without septic shock (R65.20) — organ dysfunction without vasopressor requirement or lactate threshold met; or (c) Unable to determine.”
🦴 Anatomy & Pathophysiology
Understanding shock pathophysiology enables CDI specialists to recognize when hemodynamic deterioration reflects a specific shock subtype requiring documentation and when comorbid organ dysfunction codes must be captured.
Shared Pathophysiological Pathway
Regardless of subtype, all shock states converge on the same final common pathway: decreased oxygen delivery (DO2) relative to oxygen consumption (VO2) → anaerobic metabolism → lactate accumulation → cellular energy failure → organ dysfunction → death. Per UpToDate: Shock Definition and Classification, DO2 = CO × CaO2, where cardiac output (CO) = HR × SV, making any reduction in HR, SV, or arterial oxygen content a potential trigger.
Subtype-Specific Pathophysiology
- Septic shock: Pathogen-associated molecular patterns (PAMPs) activate innate immunity → cytokine storm (TNF-α, IL-1, IL-6) → endothelial dysfunction → vasoplegia (profound ↓SVR) → distributive hypoperfusion. Myocardial depression (sepsis cardiomyopathy) further reduces CO. Microvascular thrombosis and capillary leak compound organ injury. Per Sepsis-3 criteria (JAMA 2016).
- Cardiogenic shock: Acute loss of left ventricular contractility (most commonly from AMI — per AHA/ACC 2022 Cardiogenic Shock Guidelines) → ↓SV → compensatory ↑SVR → further ↑afterload → vicious cycle of worsening pump failure. Pulmonary edema results from ↑LVEDP and ↑PCWP.
- Hypovolemic shock: ↓Preload from blood/fluid loss → ↓SV → ↑HR, ↑SVR (compensatory) → insufficient to maintain CO → end-organ ischemia. Four hemorrhagic shock classes (I–IV) based on estimated blood loss per ATLS 10th Edition: Class III (>30% EBL) and IV (>40% EBL) carry life-threatening hemodynamic compromise.
- Obstructive shock: Mechanical impedance to RV outflow (PE) or ventricular filling (tamponade, tension pneumo) → ↓CO despite normal/↑cardiac filling pressures. Tamponade: pericardial fluid compresses cardiac chambers (pulsus paradoxus reflects inspiratory ↓LV filling). PE: acute RV dilation → interventricular septal shift → ↓LV preload.
- Anaphylactic shock: IgE-mediated mast cell/basophil degranulation → histamine, tryptase, leukotrienes, prostaglandins → ↓↓SVR + ↑vascular permeability + bronchospasm. The distributive pattern is similar to septic shock but onset is rapid (seconds to minutes). Per AAAAI/ACAAI Anaphylaxis Guidelines 2020.
Organ Dysfunction Coding Opportunities
Shock-induced organ dysfunction must be documented and coded separately when present. Each complication is typically an MCC or CC that significantly affects DRG assignment:
- Acute kidney injury (N17.0–N17.9) — most common; document stage (oliguric, anuric, requiring dialysis)
- Acute respiratory failure (J96.00–J96.01) — type 1 (hypoxic) vs. type 2 (hypercapnic)
- Acute hepatic failure (K72.00–K72.01) — “shock liver,” transaminitis >1000 IU/L
- DIC (D65) — septic, obstetric, and traumatic shock
- Encephalopathy (G93.40, G93.41) — septic encephalopathy when provider-documented
- Coagulopathy (D68.9 or specific) — distinguish from DIC
💊 Medication Impact / Treatment
Vasopressor and inotrope administration is the pharmacologic hallmark of hemodynamically significant shock. Documentation of which agents were used, for how long, and at what doses supports clinical validity for shock diagnosis and has direct impact on HCPCS coding (Part B/outpatient) and nursing acuity capture.
Vasopressors (First-Line)
- Norepinephrine (Levophed): First-line vasopressor for septic shock per Surviving Sepsis Campaign 2021. Acts on α1-adrenergic receptors → ↑SVR. HCPCS: typically J3490 (unlisted drug) or report by NDC.
- Vasopressin: Second-line agent to reduce norepinephrine requirements in septic shock; acts on V1 receptors. HCPCS: J3364 (not separately billable inpatient; J3490 outpatient).
- Epinephrine (J0171): Preferred for anaphylactic shock (IM auto-injector or IV infusion); also used in refractory septic/cardiogenic shock. HCPCS J0171 per 0.1 mg.
- Dopamine (J1265): No longer first-line for septic shock (higher arrhythmia risk per De Backer NEJM 2010); still used in certain cardiogenic shock scenarios. HCPCS J1265 per 40 mg.
- Dobutamine (J1250): Inotrope for cardiogenic shock; ↑CO without significant vasoconstriction. HCPCS J1250 per 250 mg.
Adjunctive Medications
- Hydrocortisone (J1720): For septic shock refractory to vasopressors — 200 mg/day IV per Surviving Sepsis Campaign 2021. HCPCS J1720 (up to 100 mg) or J1710 (up to 25 mg); inpatient covered under DRG — not separately billable Part B inpatient.
- Diphenhydramine + H2 blocker: Adjunctive for anaphylactic shock (not first-line; epinephrine remains first-line).
- Broad-spectrum antibiotics: Mandatory within 1 hour for septic shock per Surviving Sepsis Campaign; selection drives organism-specific coding (A41.x).
- IV crystalloids (0.9% NS or LR): 30 mL/kg initial bolus for septic shock; large-volume resuscitation for hypovolemic shock. Balanced crystalloids preferred per SMART Trial NEJM 2018.
- Naloxone (J2310): For opioid-related distributive shock/hemodynamic compromise. HCPCS J2310 per 1 mg.
- Morphine (J2270): Used in cardiogenic shock/acute pulmonary edema context (use with caution; CAUTION-HF data suggests potential harm). HCPCS J2270 per 10 mg.
Mechanical Circulatory Support
- Intra-aortic balloon pump (IABP): CPT 33967/33968 insertion/removal; augments coronary perfusion in cardiogenic shock
- Percutaneous VAD (Impella, TandemHeart): CPT 33990, 33991, 33994–33996 for insertion; 33992, 33997, 33998 for removal; 33993 for repositioning. Select the exact CPT 2027 code by chamber/access/approach and documentation.
- ECMO/ECLS: CPT 33946–33989 family, selected by daily management/initiation, cannulation, decannulation/removal, patient age, site, and approach; used for refractory cardiogenic or septic shock with combined cardiac and respiratory failure
- 33994, 33996, 33998: added to the percutaneous VAD family for CPT 2027; not reportable for CPT 2026 dates of service.
- For 2026 dates of service, use the CPT 2026 VAD and ECMO/ECLS code set and descriptors in effect for that date of service.
Preview ends here. The full guide continues with FY2027 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.
← Back to All Clinical Documentation Guides
📘 ICD-10-CM Guidelines
Shock is governed by multiple sections of the FY2027 ICD-10-CM Official Guidelines for Coding and Reporting. Sequencing errors in shock — particularly septic shock — are among the most common and financially consequential audit findings in inpatient coding.
Per FY2027 ICD-10-CM Official Guidelines Section I.C.1.d.2: Septic shock (R65.21) cannot be sequenced as the principal diagnosis. The code for the underlying systemic infection — such as A41.x (sepsis due to specific organism) or the specific infection code — must always be sequenced first (PDx), followed by R65.21, followed by any acute organ dysfunction codes. This is a mandatory sequencing rule, not a guideline suggestion. Violation results in an incorrect DRG assignment and constitutes a compliance risk under OIG audit programs. The same principle applies to severe sepsis (R65.20): the infection code precedes R65.20, then organ dysfunction codes follow.
Guideline I.C.1.d — Sepsis and Septic Shock Sequencing
- I.C.1.d.1: For a patient admitted for sepsis (A41.9 or specific A41.x), the sepsis code is PDx. When sepsis results from a localized infection (e.g., UTI, pneumonia), the sepsis code still goes first if sepsis is the reason for admission. The localized infection is coded as an additional diagnosis.
- I.C.1.d.2: A code from subcategory R65.2- (severe sepsis) is required any time sepsis is documented with organ dysfunction. R65.20 = without shock; R65.21 = with septic shock.
- I.C.1.d.5: Septic shock. If the reason for admission is septic shock, sequence: (1) systemic infection code, (2) R65.21, (3) any acute organ dysfunction codes. Per guideline: “Code R65.21, Severe sepsis with septic shock, can never be assigned as a principal diagnosis.”
- I.C.1.d.6: Severe sepsis may be present on admission or develop during the admission. If it develops post-admission, the underlying infection is still PDx; R65.20 or R65.21 is added as secondary.
Guideline I.C.19 — Injury, Traumatic Shock
Traumatic shock (T79.4xxA) is classified under Chapter 19 (Injury/Poisoning). Per Guideline I.C.19, the most severe injury is typically sequenced as PDx. T79.4xxA is reported as an additional code when traumatic shock complicates the injury. The 7th character “A” denotes initial encounter; “D” subsequent; “S” sequela.
Guideline I.C.15 — Obstetric Shock
Shock occurring during or following labor/delivery is coded to O75.1 (Shock during or following labor and delivery). Chapter 15 (Obstetric) codes take precedence over R57.x codes in obstetric patients. O75.1 is always an additional code — the obstetric complication/condition causing the shock is PDx.
Guideline I.C.19 — Postprocedural Shock (T81.1x)
Shock occurring in the postoperative period is coded to T81.1x when it represents a complication of the procedure itself. Key distinctions:
- T81.10xA: Postprocedural shock, unspecified — use only when subtype cannot be determined
- T81.11xA: Postprocedural cardiogenic shock
- T81.12xA: Postprocedural septic shock (+ infection code as PDx)
- T81.19xA: Other postprocedural shock (hypovolemic, anaphylactic)
Do NOT use T81.1x if the shock pre-dated the procedure or is clearly attributable to the underlying condition rather than the procedure itself. CDI query is appropriate when this distinction is unclear.
Guideline I.C.1 / I.C.19 — Anaphylactic Shock Cause Documentation
Anaphylactic shock codes require identification of the causative agent. The appropriate T-code (T78.0x for food, T80.5 for serum, T88.6 for drug adverse effect) is sequenced as the primary code for anaphylaxis, with 7th characters required: A (initial), D (subsequent), S (sequela). When cause is unknown, T78.2xxA is used.
Unlike septic shock, R57.0 (cardiogenic shock) and R57.1 (hypovolemic shock) may serve as principal diagnosis when the shock itself is the reason for admission and the underlying cause was not established until after admission. However, when the underlying condition (e.g., acute MI for cardiogenic shock, GI hemorrhage for hypovolemic shock) drove the admission, the underlying condition is typically PDx. Clinical documentation clarity is essential — CDI should ensure the admitting indication and the primary reason for care are explicitly stated.
CC/MCC Status — Major DRG Impact
Per CMS FY2026 MS-DRG Definitions Manual: R57.0, R57.1, R57.8, R57.9, R65.21, and T79.4xxA are all classified as Major Complication/Comorbidity (MCC) when coded as secondary diagnoses. A single MCC can elevate a DRG by $3,000–$8,000+ in reimbursement. Missing a shock complication or failing to document shock type (accepting R57.9 or omitting R65.21 when septic shock meets Sepsis-3 criteria) constitutes a significant missed revenue and documentation quality opportunity.
🔢 ICD-10-CM Code Set (Tabular)
| ICD-10-CM Code | Description | CC/MCC Status | Coding Notes |
|---|---|---|---|
| R57.0 | Cardiogenic shock | MCC | SBP <90 >30 min, CI <2.2, PCWP >15. May be PDx or secondary. With AMI: I21.x + R57.0 → DRG 219/220/221. |
| R57.1 | Hypovolemic shock | MCC | Code underlying cause (hemorrhage, dehydration) separately. May be PDx or secondary depending on admission. |
| R57.8 | Other shock (endocrine, neurogenic, spinal) | MCC | Use for neurogenic/spinal shock (+ SCI code), adrenal crisis shock (+ E27.x), distributive NOS not otherwise specified. |
| R57.9 | Shock, unspecified | MCC | AUDIT TRAP — always query for subtype. Per FY2027 Guidelines, code to highest specificity available. R57.9 should be rare in a well-queried chart. |
| R65.20 | Severe sepsis without septic shock | MCC | Use when sepsis with organ dysfunction but NO vasopressor-dependent hypotension meeting Sepsis-3 shock criteria. Sequence: infection code first, then R65.20, then organ dysfunction codes. |
| R65.21 | Severe sepsis with septic shock | MCC | NEVER PDx. Always secondary to A41.x or specific infection code. Lactate >2 + vasopressor-requiring hypotension despite resuscitation required per Sepsis-3. |
| T78.2xxA | Anaphylactic shock, unspecified cause, initial encounter | MCC | Use when causative agent cannot be determined. 7th character required: A=initial, D=subsequent, S=sequela. |
| T78.00xA | Anaphylactic reaction due to unspecified food, initial encounter | MCC | Use T78.01xA–T78.09xA for specific food allergens (peanuts T78.01, shellfish T78.02, fish T78.03, milk T78.07, eggs T78.08, other T78.09). |
| T78.01xA | Anaphylactic reaction due to peanuts, initial encounter | MCC | Specific food anaphylaxis — document causative food in chart. |
| T78.07xA | Anaphylactic reaction due to milk and dairy products, initial encounter | MCC | Common pediatric anaphylaxis trigger. |
| T80.5xxA | Anaphylactic reaction due to serum, initial encounter | MCC | Serum/vaccine/immunoglobulin-related anaphylaxis. For COVID-19 vaccine reactions, see the COVID-19 guide; current US COVID-19 vaccines are not serum based (AHA COVID-19 FAQ). |
| T88.6xxA | Anaphylactic reaction due to adverse effect of correct drug properly administered, initial encounter | MCC | Adverse effect (correct drug, correct dose). Additional code for drug (T36–T50 with 5th/6th character “5”). Distinguish from T88.7 (unspecified adverse effect). |
| T81.10xA | Postprocedural shock, unspecified, initial encounter | MCC | Use only when postprocedural shock subtype cannot be determined. 7th character A/D/S required. |
| T81.11xA | Postprocedural cardiogenic shock, initial encounter | MCC | Post-cardiac surgery or non-cardiac procedure cardiogenic shock. Code underlying procedure complication additionally. |
| T81.12xA | Postprocedural septic shock, initial encounter | MCC | Post-surgical infection progressing to shock. Code infection code first (as PDx if infection drove admission), then T81.12xA, then organ dysfunction. |
| T81.19xA | Other postprocedural shock (hypovolemic, anaphylactic), initial encounter | MCC | Postprocedural hypovolemic or anaphylactic shock (e.g., contrast reaction post-procedure). |
| T79.4xxA | Traumatic shock, initial encounter | MCC | Shock complicating major trauma. Code most severe injury as PDx; T79.4xxA as additional. 7th character required. |
| O75.1 | Shock during or following labor and delivery | MCC | Obstetric setting — do NOT use R57.x. Chapter 15 codes take precedence. Code obstetric cause as PDx. |
| A48.3 | Toxic shock syndrome | MCC | Toxin-mediated toxic shock syndrome. Use an additional code from B95–B96 to identify the organism when documented (e.g., staphylococcal or streptococcal). Do not add R65.21 solely to represent toxic shock syndrome; report severe sepsis/septic shock only when separately documented and supported. |
| I26.02 | Saddle embolus of pulmonary artery with acute cor pulmonale | MCC | Massive PE with obstructive shock mechanism. No separate R57.x typically needed when PE code captures hemodynamic severity. |
| I26.09 | Other pulmonary embolism with acute cor pulmonale | MCC | Submassive/massive PE with RV failure — obstructive shock pathway. |
| I31.4 | Cardiac tamponade | MCC | Obstructive shock mechanism. R57.0 may be added if provider explicitly documents cardiogenic shock component. |
Correct sequencing for septic shock: (1) A41.x or specific infection code → (2) R65.21 → (3) acute organ dysfunction codes (e.g., N17.9 AKI, J96.00 ARF, K72.00 acute liver failure, D65 DIC). Example: Sepsis due to E. coli with septic shock and AKI = A41.51 (PDx) + R65.21 + N17.9. Per FY2027 Guidelines I.C.1.d.2.
🔎 Indexing
The following alphabetic index entries are essential for shock code lookups in the FY2026 ICD-10-CM Tabular List and Alphabetic Index:
| Index Term | Subterm / Modifier | Code |
|---|---|---|
| Shock | (main entry) | R57.9 |
| Shock | cardiogenic | R57.0 |
| Shock | hypovolemic | R57.1 |
| Shock | endocrine | R57.8 |
| Shock | neurogenic | R57.8 |
| Shock | spinal — see Injury, spinal cord, by region | R57.8 + SCI code |
| Shock | anaphylactic — see Anaphylaxis | T78.2xxA (unspecified) |
| Shock | anaphylactic due to food | T78.00xA–T78.09xA |
| Shock | anaphylactic due to serum | T80.5xxA |
| Shock | anaphylactic due to adverse effect of drug | T88.6xxA |
| Shock | traumatic | T79.4xxA |
| Shock | following labor and delivery | O75.1 |
| Shock | postprocedural (unspecified) | T81.10xA |
| Shock | postprocedural cardiogenic | T81.11xA |
| Shock | postprocedural septic | T81.12xA |
| Shock | postprocedural, other | T81.19xA |
| Sepsis | with septic shock (severe sepsis) | A41.9 + R65.21 |
| Septic shock | — see Sepsis | R65.21 (never alone) |
| Anaphylaxis | (main entry) | T78.2xxA |
| Toxic shock syndrome | (main entry) | A48.3 |
| Syndrome | toxic shock | A48.3 |
Indexing Tip: When “shock” appears in documentation without a subtype modifier, always look up “Shock” in the Alphabetic Index and follow the “see also” cross-references. The tabular instruction at R57 states: “Code also the underlying condition” — this reinforces the mandatory dual-coding approach for most shock subtypes.
🏥 CPT
The following CPT 2026 codes are most commonly reported in the evaluation and management of shock and its complications. Critical care codes (99291-99292) are central to shock encounters in the ICU and emergency department setting.
| CPT Code | Description | Global | Coding Notes |
|---|---|---|---|
| 99291 | Critical care, evaluation and management, first 30–74 minutes | XXX | Foundation code for ICU shock management. Document time clearly. Both inpatient and ED applicable. Per AMA CPT 2026. |
| 99292 | Critical care, each additional 30 minutes (list separately with 99291) | ZZZ | Add-on code; requires 75+ total critical care minutes. Document cumulative time. |
| 36556 | Insertion, non-tunneled centrally inserted central venous catheter, age ≥5 years | 000 | CVC for vasopressor delivery and CVP monitoring. Distinct from PICC (36568–36569). |
| 36558 | Insertion, tunneled centrally inserted central venous access device, with subcutaneous port, age ≥5 years | 000 | For longer-term vascular access in prolonged shock/ICU care. |
| 36620 | Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous | 000 | A-line placement for continuous BP monitoring in hemodynamically unstable shock patients. |
| 36640 | Arterial catheterization for prolonged infusion therapy | 000 | Intra-arterial medication delivery; less common but coded separately when performed. |
| 93451 | Right heart catheterization including measuring right atrial, right ventricular, pulmonary artery and pulmonary wedge pressures | 000 | Swan-Ganz/PA catheter for hemodynamic profiling in cardiogenic shock (CI, PCWP, CO measurement). |
| 93453 | Combined right and left heart catheterization | 000 | Used when both RV and LV function assessment needed (cardiogenic shock with AMI). |
| 93456–93464 | Right/left heart cath with coronary angiography (various combinations) | 000 | AMI-cardiogenic shock workup — coronary anatomy and hemodynamics. |
| 93355 | Echocardiography, transesophageal (TEE), including probe placement, image acquisition, interpretation and report; during non-cardiac procedure, for monitoring purposes | 000 | Hemodynamic monitoring in cardiogenic shock, tamponade assessment, ECMO cannula positioning. |
| 93880 | Duplex scan of extracranial arteries; complete bilateral study | 000 | Vascular assessment in shock context (neurogenic shock evaluation, vascular injury). |
| 33967 | Insertion of intra-aortic balloon pump, non-surgical | 000 | IABP for cardiogenic shock — counterpulsation to reduce afterload and improve coronary perfusion. |
| 33990, 33991, 33994–33996 | Insertion of percutaneous ventricular assist device (VAD), including radiological supervision and interpretation; code selection depends on chamber/access/approach | 000 | Percutaneous VAD support for cardiogenic shock — documents mechanical circulatory support. Per AMA CPT 2027; select the exact code from the operative note and current CPT descriptor. |
| 33991 | Insertion of percutaneous ventricular assist device (VAD), including radiological supervision and interpretation; both arterial and venous access, with transseptal puncture | 000 | Percutaneous VAD support when both arterial and venous access with transseptal puncture is documented. |
| 33992, 33997, 33998 | Removal of percutaneous ventricular assist device at a separate and distinct session from insertion; code selection depends on device/chamber/access | 000 | Report the applicable removal code when VAD removal is documented as a separate and distinct session from insertion. |
| 33993 | Repositioning of percutaneous ventricular assist device | ZZZ | Add-on code; repositioning documented distinctly from insertion session. |
| 33946–33949 | ECMO/ECLS daily management/initiation services, as applicable | 000/ZZZ | ECMO/ECLS support for refractory cardiogenic or cardiorespiratory shock; report cannulation and decannulation/removal separately when performed and supported. |
| 33951–33956 | ECMO/ECLS cannula insertion codes, as applicable by age, site, approach, and cannula type | 000 | Report when ECMO/ECLS cannulation is performed and separately reportable under CPT guidance. |
| 33965, 33966, 33969, 33984–33986 | ECMO/ECLS cannula removal/decannulation codes, as applicable by age, site, and approach | 000 | Report when ECMO/ECLS cannula removal/decannulation is performed and separately reportable under CPT guidance. |
- 33994, 33996, 33998: added to the percutaneous VAD family for CPT 2027; not reportable for CPT 2026 dates of service.
- For 2026 dates of service, use the CPT 2026 percutaneous VAD code set and descriptors in effect for that date of service.
- For 2026 dates of service, verify ECMO/ECLS code selection against the CPT 2026 ECMO/ECLS code family in effect for that date of service.
🧾 HCPCS
HCPCS Level II codes are relevant for outpatient/emergency department administration of vasopressors and other shock-related drugs. Note: for inpatient admissions under MS-DRG, drugs are included in the DRG payment and are not separately billable under HCPCS Part B. HCPCS drug codes apply primarily in outpatient, observation, and Part B settings, or for DME/home infusion.
| HCPCS Code | Drug / Description | Unit | Typical Use in Shock |
|---|---|---|---|
| J0171 | Injection, epinephrine, 0.1 mg | Per 0.1 mg | First-line treatment for anaphylactic shock; IV/IM administration. Also used in refractory septic/cardiogenic shock. |
| J1250 | Injection, dobutamine HCl, per 250 mg | Per 250 mg | Positive inotrope for cardiogenic shock — increases contractility and cardiac output without significant vasoconstriction. |
| J1265 | Injection, dopamine HCl, 40 mg | Per 40 mg | Historical vasopressor/inotrope; now second-line. Low-dose “renal-dose” dopamine no longer recommended per evidence-based guidelines. |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | Per 100 mg | Adjunctive treatment for vasopressor-refractory septic shock; also anaphylaxis adjunct. 200 mg/day IV per Surviving Sepsis Campaign. |
| J1710 | Injection, hydrocortisone sodium phosphate, up to 25 mg | Per 25 mg | Alternative hydrocortisone formulation for septic shock adjunct therapy. |
| J2270 | Injection, morphine sulfate, up to 10 mg | Per 10 mg | Analgesia in cardiogenic shock/ACS; use with caution (CAUTION-HF data). Symptom management in end-stage shock. |
| J2310 | Injection, naloxone HCl, per 1 mg | Per 1 mg | Reversal of opioid-related distributive shock/hemodynamic depression. High-frequency use in opioid overdose presentations. |
| J3490 | Unclassified drugs | Per dose | Norepinephrine (Levophed) — no specific HCPCS J-code; report by NDC with J3490 in outpatient/ED setting. Vasopressin similarly unlisted. Per CMS HCPCS 2026. |
| J3364 | Injection, vasopressin, per unit | Per unit | Vasopressin (ADH/Pitressin) — when available as a classified code; verify current CMS HCPCS file. Used as adjunct vasopressor in septic shock. |
| A9270 | Non-covered item or service | — | Some unlisted shock interventions; verify with payer-specific guidelines. |
For inpatient MS-DRG encounters, vasopressor drugs (norepinephrine, vasopressin, epinephrine, dopamine, dobutamine) are included in the DRG bundled payment — they are NOT separately billed on the UB-04 claim under HCPCS codes. HCPCS drug codes (J0171, J1250, J1265, etc.) apply in outpatient hospital, physician office, observation, and Part B settings. For critical access hospital (CAH) outpatient and ED encounters, bill the applicable HCPCS with applicable NPI and applicable quantity based on units administered.
📚 AHA Coding Clinic
Verified AHA Coding Clinic and guideline sources for shock coding:
- Septic shock is never principal (FY 2027 Official Guidelines, Section I.C.1.d.2): “Septic shock generally refers to circulatory failure associated with severe sepsis, and therefore, it represents a type of acute organ dysfunction.” Assign the systemic infection code first, then R65.21. R65.21 is never principal.
- Code to documentation (Coding Clinic, Third Quarter 2016): Assign R65.21 from the provider’s statement of septic shock, not from vasopressor use or lactate values alone. Clinical validation is a separate process; query when indicators and documentation conflict.
- Severe sepsis link (Coding Clinic, Fourth Quarter 2017): An organ dysfunction counts toward severe sepsis only when the provider links it to the sepsis or documents severe sepsis. Query when the link is unclear.
- Cardiac arrest with cardiogenic shock (Coding Clinic, Third Quarter 2020): When a patient has both cardiac arrest and cardiogenic shock, assign only I46.9. R57.0 is a Chapter 18 code, and the cardiac arrest is the more definitive diagnosis.
- Hypovolemic shock with volume depletion (Coding Clinic, Second Quarter 2019): When dehydration or volume depletion and hypovolemic shock are both documented, assign only R57.1. The E86 Excludes1 note prevents reporting both.
- Postprocedural shock (FY 2027 Tabular List, T81.1-): T81.10- (unspecified), T81.11- (cardiogenic), T81.12- (septic), and T81.19- (other) identify shock during or following a procedure. For postprocedural septic shock, follow the T81.12- “code first” and “use additional code” notes for the infection.
- Anaphylactic shock (FY 2027 Tabular List, T78.2, T78.0-, T80.5-, T88.6): Use the code for the cause when documented: food (T78.0-), serum (T80.5-), or a correctly administered drug (T88.6 with a T36–T50 adverse-effect code). T78.2- is for anaphylactic shock of unspecified cause.
- Risk adjustment note: In the 2027 Initial mappings, R65.20, R65.21, R57.1 (hypovolemic shock), and R57.8 (other shock) map to CMS-HCC V28 HCC 2. R57.0 (cardiogenic shock), R57.9 (shock, unspecified), and J96.0- (acute respiratory failure) map to V28 HCC 213 (Cardio-Respiratory Failure and Shock). T81.1- postprocedural shock codes do not map to a V28 payment HCC.
Source note: Coding Clinic items were read in full on Find-A-Code (AHA Coding Clinic for ICD-10-CM and ICD-10-PCS). Items without a Coding Clinic issue rest on the FY 2027 Official Guidelines or Tabular List, as labeled. Codes valid as of the FY 2027 ICD-10-CM code set; HCCs per the 2024 CMS-HCC model (V28), 2027 Initial mappings.
💰 HCC / Risk Adjustment
Under the 2024 CMS-HCC model (V28), shock codes split between two payment HCCs. Code the cause of the shock as well, because the cause often maps to its own HCC.
| ICD-10-CM code | CMS-HCC V28 | Coefficient (community, non-dual, aged) | Notes |
|---|---|---|---|
| R65.21 (with the systemic infection code first) | HCC 2 | 0.500 | Severe sepsis with septic shock. |
| R57.1, R57.8 | HCC 2 | 0.500 | Hypovolemic shock; other shock. Coding Clinic advised assigning only R57.1 when dehydration or volume depletion and hypovolemic shock are both documented, because R57.1 better captures the severity and the Excludes1 note then at E86 prohibited both codes (AHA Coding Clinic, 2Q 2019, “Hypovolemic Shock & Volume Depletion”). In the FY 2027 Tabular, hypovolemic shock NOS (R57.1) is an Excludes2 note at E86, which permits both codes when appropriate (ICD-10-CM Official Guidelines for Coding and Reporting FY 2027, Section I.A.12.b). |
| R57.0, R57.9 | HCC 213 | 0.370 | Cardiogenic shock; shock, unspecified. Coding Clinic advised assigning only I46.9 when cardiac arrest and cardiogenic shock are both documented, because R57.0 is a Chapter 18 code and cardiac arrest is the more definitive diagnosis (AHA Coding Clinic, 3Q 2020, “Cardiac Arrest with Cardiogenic Shock”). That advice cited an Excludes1 note at I46; in the FY 2027 Tabular, cardiogenic shock (R57.0) is an Excludes2 note at category I46. |
| J96.00–J96.02 | HCC 213 | 0.370 | Acute respiratory failure complicating shock; document hypoxic or hypercapnic. |
| I21.0-–I21.4 | HCC 228 | 0.252 | Acute myocardial infarction that causes cardiogenic shock, within 4 weeks of onset. |
| I26.02, I26.09, I26.99 | HCC 267 | 0.294 | Pulmonary embolism causing obstructive shock. |
| T78.2XXA, T88.6XXA, T81.1- | None | None | Anaphylactic and postprocedural shock codes do not map to a V28 payment HCC. |
Shock HCCs are supported by the record of the episode itself, usually an inpatient stay. A later visit that mentions a past episode of shock does not support HCC 2 or HCC 213. Assign R65.21 from the provider’s statement of septic shock, not from vasopressor or lactate data alone.
Sources: CMS 2027 Initial ICD-10-CM Mappings; coefficients from the 2024 CMS-HCC model (V28), CMS CY 2024 Rate Announcement, Attachment VI, used unchanged for payment year 2027. Raw coefficients before normalization and the MA coding pattern adjustment. Codes valid as of the FY 2027 ICD-10-CM code set.
✍️ CDI Query Templates
All queries below are AHIMA/ACDIS compliant — non-leading, multiple-choice format. Queries should be submitted when clinical indicators support a diagnosis not explicitly documented, when documentation is ambiguous, or when specificity is insufficient for accurate code assignment. Per ACDIS/AHIMA 2019 Query Practice Brief.
| # | Query Scenario | Query Wording (non-leading, multiple choice) |
|---|---|---|
| 1 | Shock Type Specification Chart reflects vasopressor use and hemodynamic instability; provider documents only “shock” or “hemodynamic instability.” | “Provider, the chart reflects hemodynamic compromise requiring vasopressor support. Please clarify the type of shock present during this admission: (a) Septic shock (vasopressor-requiring hypotension + lactate >2 despite fluid resuscitation, in context of infection); (b) Cardiogenic shock (pump failure, CI <2.2, PCWP >15); (c) Hypovolemic shock (hemorrhage or volume depletion); (d) Anaphylactic shock (allergic trigger); (e) Other shock — please specify; (f) Hemodynamic instability not meeting shock criteria; or (g) Unable to determine.” |
| 2 | Clinical Validity for Septic Shock Positive blood cultures, vasopressors documented, lactate 3.2; discharge summary says “sepsis” only. | “Provider, this patient’s clinical course shows: vasopressor requirement (norepinephrine), lactate 3.2 mmol/L on admission, and positive blood cultures (organism: ___). Does this patient’s condition represent: (a) Septic shock — per Sepsis-3: vasopressor-dependent hypotension + lactate >2 mmol/L despite adequate fluid resuscitation; (b) Severe sepsis without septic shock — organ dysfunction present but shock criteria not met; (c) Sepsis without severe sepsis; or (d) Unable to determine.” |
| 3 | Cardiogenic Shock + AMI Linkage Patient with STEMI undergoes PCI; post-procedure hemodynamic instability requiring pressors; cardiogenic shock not explicitly linked to AMI. | “Provider, the patient was admitted with STEMI (I21._) and subsequently required vasopressor support with hemodynamic instability. Does this hemodynamic compromise represent: (a) Cardiogenic shock complicating acute MI; (b) Postprocedural cardiogenic shock (post-PCI); (c) Acute heart failure without shock criteria; or (d) Unable to determine. If cardiogenic shock is present, please document whether it is a complication of the acute MI or the PCI procedure.” |
| 4 | Anaphylaxis Cause Identification Anaphylactic shock documented but causative agent not specified. | “Provider, anaphylactic shock was documented during this encounter. To ensure accurate ICD-10-CM code assignment, please clarify the causative agent/trigger: (a) Food allergy (please specify: peanuts, shellfish, tree nuts, milk, eggs, other); (b) Drug/medication — adverse effect of correctly administered drug (please specify drug); (c) Drug/medication — overdose or incorrect administration (please specify); (d) Contrast/dye exposure; (e) Insect venom; (f) Blood/serum product; (g) Exercise-induced or idiopathic; (h) Unknown/unable to determine.” |
| 5 | Postprocedural vs. Spontaneous Shock Patient develops hypotension requiring vasopressors on POD 1 after abdominal surgery; no clear documentation of shock type or whether procedure-related. | “Provider, the patient developed hemodynamic compromise on postoperative day 1 requiring vasopressor support. Please clarify whether this represents: (a) Postprocedural shock — directly attributable to the surgical procedure (please specify: cardiogenic T81.11, septic T81.12, other T81.19); (b) Septic shock — systemic infection with shock criteria, not directly procedurally caused; (c) Hypovolemic shock — hemorrhage or fluid loss; (d) Cardiogenic shock — cardiac cause independent of procedure; (e) Other — please specify; or (f) Unable to determine.” |
| 6 | Lactate and Vasopressor Documentation for Septic Shock Patient with bacteremia on vasopressors; lactate elevated on admission note but not referenced in discharge summary. | “Provider, the chart reflects bacteremia (A41._) with initial lactate of ___ mmol/L and vasopressor requirement (norepinephrine/vasopressin). Please confirm whether this clinical picture is consistent with: (a) Septic shock — persistent vasopressor-requiring hypotension + lactate >2 mmol/L despite ≥30 mL/kg fluid resuscitation; or (b) Bacteremia/sepsis without shock — vasopressors used for hemodynamic support not meeting formal shock threshold; or (c) Unable to determine based on available clinical data.” |
| 7 | Hypoperfusion Criteria / Shock vs. Hypotension Patient has SBP 84/50 documented but no end-organ dysfunction evidence; provider documents “hypotension.” | “Provider, the chart documents transient hypotension (SBP 84) without explicit documentation of end-organ hypoperfusion. Please clarify the clinical assessment: (a) Shock — confirmed hemodynamic compromise with evidence of end-organ hypoperfusion (elevated lactate, AKI, altered mental status, hepatic dysfunction); (b) Hypotension without evidence of end-organ dysfunction/shock; (c) Vasovagal episode/transient hemodynamic instability; or (d) Unable to determine. If shock is present, please specify subtype.” |
| 8 | Severe Sepsis vs. Septic Shock Distinction Patient with sepsis, AKI documented, vasopressors started but discharge summary documents “sepsis with AKI” without using “severe sepsis” or “septic shock.” | “Provider, the patient with documented sepsis also has acute kidney injury and required vasopressor support. Please clarify whether the patient’s condition represents: (a) Severe sepsis without septic shock (R65.20) — sepsis + acute organ dysfunction (AKI) without vasopressor-dependent hypotension meeting shock criteria; (b) Severe sepsis with septic shock (R65.21) — sepsis + organ dysfunction + vasopressor-requiring hypotension + lactate >2 despite resuscitation; (c) Sepsis with AKI without severe sepsis criteria being met; or (d) Unable to determine.” |
🧑⚕️ Treatments (Clinical)
Clinical treatment of shock is time-critical. Documentation of the specific interventions performed — and the indication for each — directly supports both clinical coding accuracy and DRG/HCC optimization. CDI specialists should ensure that the medical record reflects the full scope of resuscitative and definitive treatments provided.
Universal Shock Resuscitation (All Subtypes)
- Airway management: Endotracheal intubation (31500) and mechanical ventilation (94002–94004) when hemodynamic compromise leads to respiratory failure; adds MCC (J96.00) to the encounter
- IV access: Large-bore peripheral IVs, central venous catheter (36556–36558) for vasopressor delivery and CVP monitoring
- Continuous monitoring: Arterial line (36620) for beat-to-beat BP monitoring; pulse oximetry; cardiac telemetry
- Volume resuscitation: Crystalloid (30 mL/kg for septic shock per Surviving Sepsis Campaign 2021); balanced crystalloids preferred (SMART, SALT-ED trials); blood products for hemorrhagic shock (massive transfusion protocol when indicated)
Septic Shock Management
- Sepsis bundle completion within 1–3 hours: blood cultures × 2 (before antibiotics), broad-spectrum antibiotics, lactate measurement, 30 mL/kg crystalloid bolus, vasopressors (norepinephrine first-line)
- Source control: abscess drainage, infected catheter removal, surgical debridement — document as additional procedure codes
- Vasopressin (0.03 units/min) added for norepinephrine-sparing (Surviving Sepsis Campaign recommendation)
- Corticosteroids (hydrocortisone 200 mg/24h IV) for vasopressor-refractory shock per SSC 2021
Cardiogenic Shock Management
- Emergent revascularization (PCI/CABG) for AMI-related cardiogenic shock — CPT 92941 (PCI in setting of AMI), 33533–33536 (CABG)
- Mechanical circulatory support: IABP (e.g., 33967/33970/33973 for insertion, 33968 for removal), percutaneous VAD/Impella (33990–33998 family, as applicable), VA-ECMO/ECLS (33946–33989 family, as applicable) per AHA/ACC 2022 Cardiogenic Shock Scientific Statement
- Inotropes: dobutamine (J1250), milrinone; avoid if hypotensive without support
- Diuresis: furosemide (J1940) for volume overload after initial stabilization
- Heart transplant evaluation in refractory cardiogenic shock refractory to all medical and mechanical support
Anaphylactic Shock Management
- Epinephrine (J0171) IM (thigh) immediately — first-line, non-deferrable; 0.3–0.5 mg IM auto-injector or 1:10,000 IV for refractory anaphylaxis
- Remove/stop causative agent (stop infusion, remove stinger, etc.)
- Positioning: supine with legs elevated (unless airway compromise); Trendelenburg
- Adjunctive: diphenhydramine (H1 blocker), ranitidine/famotidine (H2 blocker), methylprednisolone (J2920) — do not delay epinephrine for adjunctive therapy
- Bronchodilators (ipratropium J7644 / albuterol J7613) for bronchospasm component
MS-DRG Impact Summary
| Clinical Scenario | Key Codes | DRG | Approx. Relative Weight |
|---|---|---|---|
| AMI + Cardiogenic Shock, w/ MCC | I21.x + R57.0 + MCC | DRG 219 | ~6.0+ |
| AMI + Cardiogenic Shock, w/ CC | I21.x + R57.0 + CC | DRG 220 | ~3.5 |
| Septic Shock (ICU) | A41.x + R65.21 + MCC | DRG 870/871 | ~4.5–6.0 |
| PE with Acute Cor Pulmonale (Obstructive Shock) | I26.02 + MCC | DRG 175 | ~3.8 |
| ECMO for Cardiogenic/Cardiorespiratory Shock | I21.x or I50.x + R57.0 + 33960 | DRG 215 | ~18.0+ (highest-cost cardiac DRG) |
- 33994, 33996, 33998: added to the percutaneous VAD family for CPT 2027; not reportable for CPT 2026 dates of service.
- For 2026 dates of service, use the CPT 2026 VAD and ECMO/ECLS code set and descriptors in effect for that date of service.
🎓 Patient Education / Summary
What is Shock? (Plain Language)
Shock is a medical emergency in which the body’s vital organs — heart, brain, kidneys — are not receiving enough blood and oxygen to function properly. Unlike the everyday meaning of being “shocked” by surprise, medical shock is a physical collapse of blood circulation. There are different types depending on the cause: an infection can trigger septic shock, a heart attack can cause cardiogenic shock, severe bleeding causes hypovolemic shock, a massive blood clot in the lungs can cause obstructive shock, and a severe allergic reaction causes anaphylactic shock. All types require immediate emergency treatment.
Why Documentation Matters (CDI Relevance)
From a clinical documentation and coding perspective, the type of shock documented determines:
- DRG assignment and reimbursement: All shock codes are MCC — missing shock documentation can reduce DRG payment by thousands of dollars per admission
- HCC risk adjustment: Septic shock (HCC 2, ~0.355 RAF) drives significant Medicare Advantage capitation adjustments — accurate annual documentation ensures appropriate funding for patient care
- Quality metrics: Sepsis core measures (SEP-1 bundle compliance) are tracked by CMS; complete shock documentation supports accurate quality measure reporting
- Audit defensibility: Clear provider documentation of shock type, vasopressor requirement, lactate levels, and organ dysfunction protects against OIG/RAC audit findings
Key Documentation Reminders for Clinicians
- Always specify the type of shock — do not document “shock” alone; specify septic, cardiogenic, hypovolemic, anaphylactic, or obstructive
- For septic shock: document (1) the infection source and organism, (2) vasopressor requirement, (3) lactate level and response to resuscitation — this directly corresponds to the Sepsis-3 definition and supports R65.21
- For cardiogenic shock complicating AMI: explicitly link the shock to the acute MI in your documentation; specify AMI type (STEMI vs. NSTEMI) and location
- For anaphylactic shock: document the causative agent when identified — this enables specific T-code assignment and is required for complete coding
- Avoid vague language: “hemodynamically unstable,” “pressors required,” “circulatory compromise” — while these support clinical picture, the explicit diagnosis of “[type] shock” provides the legal basis for code assignment
- Document all evidence of end-organ hypoperfusion: lactate values, urine output (mL/hr), creatinine trend, mental status changes, hepatic enzymes — these support both clinical validity and organ dysfunction code assignment
Common Patient/Family Questions (CDI Context)
- “Why did the doctor say ‘septic shock’ vs. just ‘sepsis’?” — Septic shock is the most severe form of sepsis; it means the infection has caused blood pressure to drop so severely that vasopressor medications (drugs to keep blood pressure up) are required, AND the blood lactate level (a marker of cellular oxygen shortage) remains elevated despite IV fluids. Both criteria must be met.
- “Is ‘heart failure’ the same as ‘cardiogenic shock’?” — No. Heart failure means the heart is not pumping efficiently; cardiogenic shock means the pumping failure is so severe that vital organs are not receiving adequate blood flow and intervention is immediately life-threatening without mechanical or pharmacological support.
- “Can shock be caused by an allergy?” — Yes. Anaphylactic shock is a severe, whole-body allergic reaction that causes blood vessels to dilate massively and blood pressure to drop catastrophically. Epinephrine (adrenaline) is the only first-line treatment — antihistamines alone are insufficient for anaphylactic shock.
Quality Measure Intersections
- SEP-1 (Severe Sepsis and Septic Shock Bundle): CMS Hospital Inpatient Quality Reporting Program measure; tracks blood culture timing, antibiotic timing, fluid resuscitation, and vasopressor initiation in septic shock. Coding accuracy for R65.21 directly affects SEP-1 denominator capture.
- PC-02 (Elective Delivery): Not directly applicable, but O75.1 (obstetric shock) encounter data feeds into maternal quality reporting.
- OP-27 / Hospital-Acquired Condition (HAC) Reduction: Certain postprocedural shock scenarios (T81.12xA — postprocedural septic shock) may trigger HAC review if hospital-onset sepsis is flagged. CDI should ensure accurate distinction between community-acquired and hospital-onset infection in surgical patients.
About this Guide
This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2027 ICD-10-CM (effective October 1, 2026). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.
Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)
Ready to turn this knowledge into a credential?
These Clinical Documentation Guides are a free companion to CCO’s paid training programs. Browse our full CCO Course, Blitz & Practice Exam Catalog — every core course, review blitz, practice exam, textbook, and free resource in one place — and find the perfect next step for your coding career.
CCO Hero
Know someone starting a medical coding career?
Share your personal CCO link. Your friend saves 20% on their first course or practice exam of $100 or more, and you earn 5% cash on their first enrollment over $100.
Become a CCO Hero